Takeda Pharmaceutical (TSE:4502), (NYSE:TAK) is a global biopharmaceutical company focused on bringing forward innovative medicines and treatments to patients worldwide. Its operations span across several therapeutic areas, including oncology, gastroenterology, neuroscience, and rare diseases. Takeda is continually working on research and development projects, aiming to deliver life-transforming treatments and tackle unmet medical needs. The company's objective is not only to drive scientific discovery but also to ensure access to its medicines for people who need them the most, demonstrating a commitment to better health and a brighter future for millions around the globe.